Zugriffe | |
---|---|
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years | 3 |
Februar 2024 | März 2024 | April 2024 | Mai 2024 | Juni 2024 | Juli 2024 | August 2024 | |
---|---|---|---|---|---|---|---|
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years | 0 | 0 | 0 | 0 | 0 | 2 | 1 |